v3.26.1
Segment Information - Schedule of Significant Segment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Schedule of Significant Segment Expenses [Line Items]        
Other expense – direct listing offering costs $ (124) $ (586) $ (124)
Net loss and comprehensive loss (1,380) (1,008) (3,924) (6,060)
Lysosomal Storage Disorders Segment [Member]        
Schedule of Significant Segment Expenses [Line Items]        
Research and development expenses (excluding stock compensation) (719) (476) (1,398) (848)
General and administrative expenses (excluding stock compensation) (661) (300) (1,473) (528)
Stock-based compensation (108) (467) (4,560)
Other expense – direct listing offering costs (124) (586) (124)
Net loss and comprehensive loss $ (1,380) $ (1,008) $ (3,924) $ (6,060)